Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medco Settlement Will Become PBM "Gold Standard," Prosecutors Say

This article was originally published in The Pink Sheet Daily

Executive Summary

Prosecutors hope that other PBMs will adopt codes of conduct based on Medco's settlement with 20 state attorneys general over unfair trade practices. Medco will pay $29.3 mil. to settle state claims, but has not yet resolved federal damages.

You may also be interested in...



Medco Pays $155 Mil. To Settle With DoJ On Fraud, Kickback Charges

Medco will enter into a corporate integrity agreement as part of the settlement covering three false claims investigations.

Medco Pays $155 Mil. To Settle With DoJ On Fraud, Kickback Charges

Medco will enter into a corporate integrity agreement as part of the settlement covering three false claims investigations.

Medco Agrees To $163 Mil. Settlement With U.S. Attorney

Details of corporate integrity agreement yet to be reached.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS059227

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel